COVID-19 and first manic episodes: a systematic review. (August 2022)

• Record Type: Journal Article
• Authors: Russo, Mirella; Calisi, Dario; De Rosa, Matteo A.; Evangelista, Giacomo; Consoli, Stefano; Dono, Fedele; Santilli, Matteo; Gambi, Francesco; Onofrj, Marco; Di Giannantonio, Massimo; Parruti, Giustino; Sensi, Stefano L.
• Is Part Of: Psychiatry research. Volume 314(2022)
• Publication Date: 2022-08
• Subjects: Sars-CoV-2 -- Mania -- First manic episodes; Psychiatry -- Periodicals; Psychiatry -- periodicals; Psychiatrie -- Périodiques; 616.89
• DOI: 10.1016/j.psychres.2022.114677
• Languages: English
• ISSNs: 0165-1781

Abstract

Highlights: First manic episodes can occur in Sars-Cov-2 infections, even in patients with mild or absent systemic symptoms. Sars-Cov-2-related mania started on average after twelve days from the infection onset. In some cases, abnormal neuroradiology, neurophysiology, or laboratory findings were observed (a complete workup is recommended to ensure appropriate treatment). Abstract: Sars-CoV-2 is a respiratory virus that can access the central nervous system, as indicated by the presence of the virus in patients' cerebrospinal fluid and the occurrence of several neurological syndromes during and after COVID-19. Growing evidence indicates that Sars-CoV-2 can also trigger the acute onset of mood disorders or psychotic symptoms. COVID-19-related first episodes of mania, in subjects with no known history of bipolar disorder, have never been systematically analyzed. Thus, the present study assesses a potential link between the two conditions. This systematic review analyzes cases of first appearance of manic episodes associated with COVID-19. Clinical features, pharmacological therapies, and relationships with pre-existing medical conditions are also appraised. Medical records of twenty-three patients fulfilling the current DSM-5 criteria for manic episode were included. Manic episodes started, on average, after 12.71±6.65 days from the infection onset. Psychotic symptoms were frequently reported. 82.61% of patients exhibited delusions, whereas 39.13% of patients presented hallucinations. A large discrepancy in the diagnostic workups was observed. Mania represents an underestimated clinical presentation of COVID-19. Further studies should focus on the pathophysiological substrates of COVID-19-related mania and pursue appropriate and specific diagnostic and therapeutic workups.